Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 9th August 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Racing body advises against injectable Omeprazole
Samples of the injectable Omeprazole 100mg/ml (BOVA UK) were found to contain low levels of testosterone.

Product found to contain low levels of testosterone

Injectable Omeprazole should not be used in racehorses due to the presence of testosterone, the British Horseracing Authority (BHA) has advised.

BHA encouraged trainers to discuss alternative treatments with their veterinary surgeons.

Analytical laboratory LGC looked at a number of products containing Omeprazole. Samples of the injectable Omeprazole 100mg/ml (BOVA UK) were found to contain low levels of testosterone.

No oral preparations were found to contain testosterone or any other anabolic steroid.

BHA warned that the possession, use or attempted use of this product could amount to a breach of the Rules of Racing.

Presence of testosterone over the permitted threshold in a sample could result in a 14-month suspension from racing and a 12-month stand down from racing for the horse, as well as other penalties for the Responsible Person.

Trainers and other industry participants were advised to remove the product from all licensed premises and not to administer the product to a thoroughbred from birth until permanent retirement from racing. 

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here. 

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com